Interní Med. 2007; 9(10): 424-428

Severe stages of chronic obstructive pulmonary disease (COPD)

prof. MUDr. Vladimír Vondra DrSc1,2
1 Plicní oddělení zdravotnického zařízení Praha 5, Smíchov
2 Pneumologické a alergologické oddělení, Praha

Severe COPD consists of stage III. (severe) and stage IV. (very severe). Contemporary exact diagnosis of COPD severity is based on post-bronchodilator verified value of spirometric obstruction. Severe COPD stages are accompanied by the highest mortality, invalidity, hospitalization rate and decrease of health related quality of life. Severe stages of COPD are 10 percent of total COPD prevalence, but these 10 percent present the majority of direct COPD economic burden. The treatment of severe COPD is currently very expensive for the necessity of regular and long-term pharmacotherapy with inhaled long-acting bronchodilators, inhaled corticosteroids and their combinations. Modern therapy must be based on three parts of therapy during all stages of COPD, especially in the severe ones – III. and IV. – prevention, pharmacotherapy and pulmonary rehabilitation.

Keywords: severe stages of COPD, III. and IV. stage, burden, diagnosis, therapy

Published: January 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vondra V. Severe stages of chronic obstructive pulmonary disease (COPD). Interní Med. 2007;9(10):424-428.
Download citation

References

  1. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoe scale as a measure of disability in patients with COPD. Thorax 1999; 54: 581-586. Go to original source... Go to PubMed...
  2. Erban J. Dlouhodobá domácí oxygenoterapie. Praha: Maxdorf 2004: 109 s.
  3. Fuhrman C, Jongla E, Nicolan J, et al. Deaths from COPD in France 1979 - 2002: a multiple cause analysis. Thorax 2006; 61: 930-934. Go to original source... Go to PubMed...
  4. Chapman KR, Manino DM, Soriano JB, et al. Epidemiology and costs of COPD. Eur Resp J 2006; 27: 188-207. Go to original source... Go to PubMed...
  5. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in USA, 1970-2002. JAMA 2005; 294: 1255-1259. Go to original source... Go to PubMed...
  6. Lacasse J, Brooks D, Golstein RS et al. Trends in epidemiology of COPD in Canada 1980-1995. Chest 1999; 116: 306-313. Go to original source... Go to PubMed...
  7. Mannino DM, Homa DM, Akinbami LJ, et al. COPD surveillance - US, 1971-2000. MM WR 2002; 51: 1-16.
  8. Smolíková L, Máček M. Fyzioterapie a pohybová léčba u chronické obstrukční plicní nemoci. Praha: Blue Wings 2002. 215 s.
  9. Světová iniciativa o CHOPN. Světová strategie diagnostiky, léčby a prevence CHOPN. Praha: Vltavín 2006. 161 s.
  10. Vondra V. Kolik stojí farmakoterapie těžkých stadií CHOPN. Respirace 2006; 12: 18-25.
  11. Vondra V, Malý M. Úmrtnost na CHOPN v ČR a SR v letech 1979 - 2003. Stud Pneumol Phtiseol 2006; 66: 49-56.
  12. Vondra V, Malý M, Švandová E, et al. Úmrtnost na chronickou obstrukční plicní nemoc v ČR v posledním půlstoletí. Respirace 2002; 8: 46-53.
  13. Van Weel J, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet 2006; 367: 550-551. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.